Qualitative and quantitative assessment of urinary cytokeratin 8 and 18 fragments compared with voided urine cytology in diagnosis of bladder carcinoma

Urology

Volumn 64, Issue 6, 2004, Pages 1121-1126

  Hakenberg, Oliver W ^a   Fuessel, Susanne ^a   Richter, Katja ^a   Froehner, Michael ^a   Oehlschlaeger, Sven ^a   Rathert, Peter ^b   Meye, Axel ^a   Wirth, Manfred P ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b Krankenhaus Duren gem GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 18; CYTOKERATIN 8;

ADOLESCENT; ADULT; ARTICLE; BLADDER CARCINOMA; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SURGICAL TECHNIQUE; TRANSITIONAL CELL CARCINOMA; URINE CYTOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KERATINS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; URINALYSIS; URINARY BLADDER NEOPLASMS; URINARY TRACT INFECTIONS; URINE;

EID: 10644249810     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2004.08.019     Document Type: Article

References (27)

1. H.G. Wiener, C.H. Mian, A. Haitel Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer? J Urol 159 1998 1876 1880
2. S. Ramakumar, J. Bhuiyan, J.A. Besse Comparison of screening methods in the detection of bladder cancer J Urol 161 1999 388 394
3. D. Zaak, A. Hofstetter The current diagnosis of superficial bladder cancer must be reconsidered Urol Int 69 2002 85 90
4. Y. Lotan, C. Roehrborn Sensitivity and specificity of commonly available tumour markers versus cytology results of a comprehensive literature review and meta-analysis Urology 61 2003 109 118
5. A.S. Glas, D. Roos, M. Deutekom Tumour markers in the diagnosis of primary bladder cancer a systematic review J Urol 169 2003 1975 1982
6. M. Sanchez-Carbayo, E. Herrero, J. Megias Comparative sensitivity of urinary CYFRA 21-1, urinary bladder cancer antigen, tissue polypeptide antigen and NMP22 to detect bladder cancer J Urol 162 1999 1951 1956
7. M. Sanchez-Carbayo, E. Herrero, J. Megias Initial evaluation of the new urinary bladder cancer rapid test in the detection of transitional cell carcinoma of the bladder Urology 54 1999 656 661
8. M. Sanchez-Carbayo, E. Herrero, J. Megias Initial evaluation of the diagnostic performance of the new urinary bladder cancer antigen test as a tumour marker for transitional cell carcinoma of the bladder J Urol 161 1999 1110 1115
9. H. van Poppel, J. Billen, H. Goethuys Serum tissue polypeptide (TPA) as tumour marker for bladder cancer Anticancer Res 16 1996 2205 2209
10. X. Fillela, V. Menendez, R. Molina TPA prognostic value in superficial bladder cancer Anticancer Res 16 1996 2173 2175
11. P. Steiber, N. Schmeller, C. Schambeck Clinical relevance of CYFRA 21-1, TPA-IRMA and TPA-LLA-mat in urinary bladder cancer Anticancer Res 16 1996 3793 3797
12. H. Bodenmüller The characteristics of CYFRA 21-1 and other cytokeratin-tests Scand J Clin Lab Invest 221 1995 60 64
13. M. Miettinen Keratin 20 immunohistochemical marker for gastrointestinal, urothelial and Merkel cell carcinomas Mod Pathol 8 1995 384 389
14. R. Moll, A. Lowe, J. Laufer Cytokeratin 20 in human carcinomas a new histodiagnostic marker detected by monoclonal antibodies Am J Pathol 140 1992 427 433
15. M. Babjuk, M. Kostirova, K. Mudra Qualitative and quantitative detection of urinary human complement factor H-related protein (BTA stat and BTA TRAK) and fragments of cytokeratins 8, 18 (UBC Rapid and UBC IRMA) as markers for transitional cell carcinoma of the bladder Eur Urol 41 2002 34 39
16. S. Sumi, K. Arai, S. Kitahara Preliminary report of the clinical performance of a new urinary bladder cancer antigen test comparison to voided urine cytology in the detection of transitional cell carcinoma Clin Chim Acta 296 2000 111 120
17. R. Heicappell, M. Schostak, M. Müller Evaluation of urinary bladder cancer antigen as a marker for diagnosis of transitional cell carcinoma of the urinary bladder Scand J Clin Lab Invest 60 2000 275 282
18. A. Silen, S.S. Rizvi, H. Letocha Evaluation of the UBC test in the urine of healthy individuals, patients with benign disorders and urinary bladder cancer Oncol Rep 7 2000 1269 1274
19. N.A. Mungan, J.L. Vriesema, C.M. Thomas Urinary bladder cancer test a new urinary tumour marker in the follow-up of superficial bladder cancer Urology 56 2000 787 792
20. S. Eissa, M. Swellam, M. Sadek Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumours J Urol 168 2002 465 469
21. H. Boman, H. Hedelin, S. Holmang Four bladder tumour markers have a disappointingly low sensitivity for small size and low grade recurrence J Urol 167 2002 80 83
22. C. Mian, M. Lodde, A. Haitel Comparison of the monoclonal UBC-ELISA test and the NMP22 test for the detection of urothelial cell carcinoma of the bladder Urology 55 2000 223 226
23. A. Giannopoulos, T. Manousakas, A. Gounari Comparative evaluation of the diagnostic performance of the BTA STAT test and urinary bladder cancer antigen for primary and recurrent bladder tumours J Urol 166 2001 470 475
24. H. Boman, H. Hedelin, S. Jacobsson Newly diagnosed bladder cancer the relationship of initial symptoms, degree of microhematuria and tumour marker set J Urol 168 2002 1955 1959
25. W.M. Murphy, L.D. Emerson, R.W. Chandler Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancer J Urol 136 1986 815 817
26. P.L. Esposti, B. Edsmyr, B. Tribukait The role of exfoliative cytology in the management of bladder carcinoma Urol Res 6 1978 197 199
27. O.W. Hakenberg, P. Franke, M. Froehner The value of conventional urine cytology in the diagnosis of residual tumour after transurethral resection of bladder carcinomas Onkologie 23 2000 252 257